INTERVENTIONS |
Intervention type
|
Intervention name
|
Dose
|
Duration
|
Intervention description
|
Group size
|
Nature of control
|
Experimental Group |
Group1:Lidocaine group (group L) |
a bolus of 25 ml (1.5mg/kg of lidocaine diluted by normal saline) followed by continuous infusion of 1.5mg/kg/h lidocaine |
Bolus doses will be given over 10 min prior to initiation of anesthesia followed by infusion till the end of the surgery .(for a maximum of 180 min |
Bolus doses will be given over 10 min prior to initiation of anesthesia followed by infusion till the end of the surgery .(for a maximum of 180 min to avoid lidocaine toxicity). After termination of the bolus dose, the patients will be oxygenated by 100% O2 for 3 min by face mask then anesthesia will be induced with intravenous propofol 2mg/ kg ,fentanyl 1.5 µg/ kg and vecuronium bromide 0.1mg/ |
32 |
Active-Treatment of Control Group |
Experimental Group |
Group 2: Magnesium sulphate group (group M) |
each patient will receive a bolus of 25 ml (30m/kg Magnesium sulphate diluted by normal saline) followed by continuous infusion of 25mg/kg/h Magnesium sulphate |
Bolus doses will be given over 10 min prior to initiation of anesthesia followed by infusion till the end of the surgery .(for a maximum of 180 min |
Bolus doses will be given over 10 min prior to initiation of anesthesia followed by infusion till the end of the surgery .(for a maximum of 180 min to avoid lidocaine toxicity). After termination of the bolus dose, the patients will be oxygenated by 100% O2 for 3 min by face mask then anesthesia will be induced with intravenous propofol 2mg/ kg ,fentanyl 1.5 µg/ kg and vecuronium bromide 0.1mg/ |
32 |
Active-Treatment of Control Group |
Experimental Group |
Group 3: Dexemedetomidine group (group D) |
each patient will receive a bolus of 25 ml (1µg/kg Dexemedetomidine diluted by normal saline) followed by continuous infusion of 0.5µg/kg/h Dexemedetomidine |
Bolus doses will be given over 10 min prior to initiation of anesthesia followed by infusion till the end of the surgery .(for a maximum of 180 min |
Patients will be premedicated with intravenous ranitidine 0.25 mg/kg, metoclopramide 0.15 mg/kg in preoperative room. On arrival in the operation theater, monitors will be attached (heart rate, NIBP, oxygen saturation, ECG) and baseline vital parameters like heart rate, systolic and diastolic blood pressure, and oxygen saturation will be recorded Bolus doses will be given over 10 min prior to i |
32 |
Active-Treatment of Control Group |